Global Human Gene Sequencing Market Forecast 2026-2030 by Application, Technology, Workflow, Product, and Country | AI and Precision Medicine Propel Market to $21.4 Billion by 2030

NGS Leads as Precision Medicine, Oncology and NIPT Adoption Accelerates, While Long-Read Sequencing, AI Bioinformatics and Pharma Partnerships Unlock OpportunitiesDublin, Oct. 09, 2026 (GLOBE NEWSWIRE ...

Who is Shankar Balasubramanian? Indian-origin scientist wins 2026 Wolf prize for DNA sequencing breakthrough

Indian-origin scientist Shankar Balasubramanian has won the 2026 Wolf Prize in Chemistry for his contribution to ...

DNA Sequencing Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $91.9 Billion as Next-Generation Sequencing Expands Oncology and Rare Disease Diagnostics

Next-generation sequencing, oncology and rare-disease diagnostics, and genomics investment drive growth, with North America leading the market.Dublin, Sept. (GLOBE NEWSWIRE) -- "DNA Sequencing Market ...
RAPS

FDA drafts guidance on using next-generation sequencing to assess gene therapy safety

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing (NGS) methods in nonclinical studies to assess the safety risks associated ...
VietnamPlus

DNA testing capacity expanded to identify over 207,000 martyrs’ remains

By September 2026, Steering Committee 515 had collected samples from the remains of 207,656 martyrs, achieving 98.15% of the ...

He discussed DNA sequencing over beers in 1997; how Shankar Balasubramanian helped transform the way the world reads genomes

In August 1997, four scientists met at a pub in Cambridge with little more than an idea about how DNA could be read faster.
nutraingredients.com

Next-gen DNA testing gains traction in botanicals

NOW has added next-generation DNA sequencing to its botanical identity testing program through a new partnership with botanical genomics company LeafWorks, reflecting broader changes in how genomic ...

Whole Genome and Exome Sequencing Markets Set for Growth Through 2030, Driven by Expanding Applications, Product Innovation and Direct-to-Consumer Opportunities; 7th Edition ...

Falling sequencing costs, precision medicine and broader clinical use are driving WGS adoption, creating opportunities in long-read platforms, automation, cloud bioinformatics and data services.Dublin ...
Finanznachrichten

F. Hoffmann-La Roche Ltd: Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform

AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes the freedom to customise their workflows and explore a wider array of ...